The Genetic Puzzle of Endometriosis Is Becoming Clearer: Largest-Ever Study Identifies 80 Genetic Risk Regions

What if endometriosis was never just a gynecologic disease?

For decades, women with endometriosis have heard phrases such as: 

“Your scans look normal.” 

“Your pain is part of being a woman.” 

“We don’t know why this is happening.”

Yet millions of women worldwide continue to experience chronic pelvic pain, fatigue, bowel symptoms, infertility, migraines, inflammation, and hormonal disruption. 

Now, a groundbreaking international study published in Nature Genetics is helping change that narrative.

Researchers analyzed the genetic information of more than 1.4 million women, including over 105,000 women diagnosed with endometriosis, making it the largest genetic study of endometriosis ever performed. The findings identified 80 genetic regions associated with endometriosis risk, including 37 newly discovered regions, providing the most comprehensive understanding to date of the biological pathways involved in this complex disease.

Why This Study Matters

Endometriosis affects approximately 1 in 10 women worldwide, yet many patients wait 7–10 years or longer to receive a diagnosis. This delay often occurs because endometriosis can affect far more than the reproductive organs. Symptoms frequently involve multiple body systems, including:

• - Chronic pelvic pain

• - Painful periods

• - Bowel dysfunction

• - Bladder symptoms

• - Fatigue

• - Migraines

• - Nausea

• - Infertility

• - Anxiety and mood changes

• - Musculoskeletal pain

The Yale-led research helps validate what many patients have known all along:  

Endometriosis is not simply misplaced uterine tissue. It is a complex inflammatory, hormonal, immune, and genetic condition affecting the entire body.

What Did Researchers Discover?

1.      Endometriosis Has a Strong Genetic Component 

The study identified 80 genetic regions that appear to increase the likelihood of developing endometriosis. 

While genetics do not determine destiny, these discoveries suggest that certain biological pathways may make some women more susceptible to developing the disease. 

This helps explain why endometriosis often appears in families and why daughters, sisters, mothers, and grandmothers frequently report similar symptoms. 

For years, patients have asked: “If my mother had endometriosis, am I at greater risk?” 

Research increasingly suggests the answer is yes.

2.      New Insights into Inflammation and Immune Dysfunction 

One of the most significant findings was the identification of pathways involved in: 

• Chronic inflammation

• Immune system regulation

• Hormonal signaling

• Tissue remodeling and fibrosis

These findings support several leading theories regarding endometriosis development. 

Researchers found evidence suggesting that abnormal immune responses may allow endometrial-like tissue to survive and grow outside the uterus instead of being cleared by the body. This reinforces growing evidence that endometriosis may represent a neuroimmune-inflammatory disease rather than simply a structural gynecologic disorder.

3.      Genetic Links Between Endometriosis and Adenomyosis

 The study identified five genetic regions shared between:

• Endometriosis

• Adenomyosis

Adenomyosis occurs when endometrial tissue grows into the muscular wall of the uterus.

Many women suffer from both conditions simultaneously, yet historically they have been studied separately. These findings suggest the two conditions may share common biological mechanisms and may represent different manifestations of overlapping disease processes.

For patients who have both diagnoses, this research offers validation that these conditions may be more closely connected than previously understood.

4.      The Future of Personalized Medicine 

Researchers also incorporated what is known as multi-omics analysis. 

This approach combines: 

• Genetics

• Protein analysis

• Tissue biology

• Molecular pathways

By integrating these data sets, scientists can begin identifying which biological pathways are most active in different patients. 

This may eventually help clinicians answer important questions such as:

• Why do some women primarily experience pain?

• Why do some struggle with infertility?

• Why do symptoms vary dramatically between patients?

• Why do some women develop aggressive disease while others do not?

Although a clinical genetic test for endometriosis is not yet available, this research represents an important step toward individualized treatment strategies.

Could Existing Medications Be Repurposed?

One particularly exciting finding involved the identification of existing FDA-apprved medications that may influence pathways involved in endometriosis. Researchers highlighted several classes of medications currently used for:

• Breast cancer

• Hormonal regulation

• Contraception

• Prevention of preterm birth

Further research will be needed, but drug repurposing may help accelerate treatment development because these medications already have established safety profiles.  

For patients, this means future therapies may arrive sooner than entirely new drugs developed from scratch.

What Does This Mean for Women Living with Endometriosis Today?

While this study will not immediately change clinical practice, it represents a major shift in how the medical community understands endometriosis.

For many years, patients were told: “We don’t know why this happens.”

Today, we are beginning to identify the biological pathways involved.

The emerging picture suggests that endometriosis involves: 

• Genetics

•  Immune dysfunction

•   Chronic inflammation

•  Hormonal signaling

•  Tissue remodeling

•  Neuroimmune interactions

This broader understanding supports a more comprehensive approach to care—one that looks beyond lesions alone and considers the whole person.

The ELYSARA Perspective

At ELYSARA,we often discuss how endometriosis extends far beyond the pelvis.

Many women continue to experience symptoms even after successful excision surgery because the disease process may involve ongoing inflammation, immune dysregulation, hormonal imbalance, nervous system sensitization, nutrient deficiencies, and metabolic changes.

Research such as this reinforces the importance of viewing endometriosis through a systems-based lens.

Surgery remains a critical component of care for many patients. However, long-term healing often requires attention to the broader biological environment that influences inflammation, hormones, immune function, and quality of life.

As science continues to uncover the genetic and molecular foundations of endometriosis, we move closer to a future where women receive:

• Earlier diagnosis

• More personalized treatment

• Better symptom management

• Improved fertility outcomes

• Greater understanding and validation

And perhaps most importantly—

A future where women no longer spend years suffering before being heard.

Research Reference

Koller D, Polimanti R, et al. 

“Multi-Ancestry Genome-Wide Association Study of Endometriosis Identifies Novel Risk Loci and Therapeutic Opportunities.” 

Published in Nature Genetics, 2026. 

Yale School of Medicine News Release:

“Largest-Ever Genetic Study of Endometriosis Uncovers 80 Risk Regions and New Avenues for Treatment” (April 29, 2026).